• Best stocks to buy now
  • Contact
  • Disclaimer
Thursday, March 30, 2023
No Result
View All Result
Best Stocks
  • News
  • Best stocks to buy now
  • Categories
    • Crypto
    • Dow Jones today
    • Pre-IPO and startups
    • Tech stocks
    • Utility stocks
  • Best Stocks toolsHOT
    • Stock News Sentiment
    • Stock Fundamentals Checker
    • Price Targets
    • Indices
  • About us
    • Contact
Best Stocks
No Result
View All Result
Home News

SG Americas Securities LLC sells CorVel Co. (NASDAQ:CRVL) stock.

Ronald Kaufman by Ronald Kaufman
January 27, 2023
in News
Reading Time: 3 mins read
A A
0
SHARES
17
VIEWS
Share on FacebookShare on Twitter

SG Americas Securities LLC decreased the number of shares of CorVel Co. (NASDAQ: CRVL) that it holds in its portfolio during the third quarter, as stated in the most recent Form 13F filing that the company has made with the SEC. The fund had 3,383 of the business services provider’s shares of stock at the end of the period, even though it had sold 1,240 shares during the preceding quarter. The total value of the holdings of CorVel that SG Americas Securities LLC had as of the close of the most recent reporting period was $468,000.

Several other institutional investors and hedge funds have recently adjusted the percentage of CRVL shares they own in their respective portfolios.

During the second quarter, Castle Wealth Management LLC paid approximately $32,000 to acquire a new position in CorVel.

During the second quarter, Eagle Bay Advisors LLC made a new investment in CorVel. The total value of this investment was somewhere around $34,000.

During the second quarter, Point72 Hong Kong Ltd.

Increased the percentage of CorVel stock that it was holding by 327.6%.

Point72 Hong Kong Ltd now owns 325 shares of the business services provider’s stock after purchasing an additional 249 shares during the most recent quarter. The current value of these shares is $48,000.

During the second quarter, Venture Visionary Partners LLC increased its holdings in CorVel by purchasing additional shares for approximately $55,000. This was done to add to the company’s overall value.

During the third quarter of this year, CWM LLC increased its holdings in CorVel by 88.5% to keep up with its competitors. CWM LLC now holds a total of 675 shares of the stock held by the business services provider after purchasing an additional 317 for a combined price of $93,000.

Institutional investors and hedge funds hold 50.75 percent of the company’s outstanding shares.
When trading started on Thursday, one share of CorVel sold for $164.78 per unit. The price of a share of stock in CorVel Company ranged from a low of $129.19 to a high of $183.20 over the previous 52 weeks. The company’s moving average price over the previous 50 days is $149.41, and the moving average price over the previous 200 days is $152.66. The company’s price-to-earnings ratio is 45.52, and its beta value is 1.00. The company’s total value, as measured by its market capitalization, is $2.84 billion.

CorVel’s (NASDAQ: CRVL) most recent quarterly earnings report was made public on November 1st, a Tuesday. The report covered the period ending September 30th.

Earnings of $0.83 per share were generated by the company that provides business services throughout the preceding quarter. The return on equity for the company was 31.22%, and the net margin for CorVel was 9.40%.

During the time frame analyzed in this report, the business brought in a total of $177.43 million in revenue.

The transaction took place on Tuesday, December 13, and it was reported elsewhere in the news that Chairman V. Gordon Clemons sold 1,066 shares of company stock. The price of $150.06 per share was determined to be the stock’s average selling price after it was sold for a total of $159,963.96 worth of shares.

As a direct consequence of the transaction, the board’s Chairman now owns 430,534 shares of the company, which have an aggregate value of $64,605,932.04 at present. Simply clicking on this link will take you to a document submitted to the SEC and provide you with additional details regarding the transaction.

According to earlier CorVel news, Executive Vice President Mark E.

Bertels sold 750 shares of the company’s stock on Tuesday, November 15. The company reported this transaction. The shares were sold for a total of $114,750.00, equivalent to an average price of $153 per share divided by the number of shares sold. The transaction resulted in the executive vice president gaining ownership of 850 shares.

Based on the current market price, these shares are worth $130,050.

If you click on this link, you will be taken to a legal filing that was made with the SEC, which will give you more information regarding the transaction and take you there immediately.
Furthermore, on December 13th, the Chairman of the Board, V. Gordon Clemons, sold 1,066 shares of the company’s stock. The price of each share was determined to be $159,963.96 in total, which is equivalent to an average price of $150.06 per share after the sale of the shares.

After the deal’s completion, the company’s Chairman is now the owner of 430,534 shares, which have a combined value of $64,605,932.04.

Disclosures that are related to the sale might be found in this section of the website. Corporate insiders sold 13,317 shares of company stock at a total price of $2,032,034 during the three months before the most recent financial reporting period. There are a total of 48.56 percent of the company’s shares that the company’s insiders hold.

In a separate development, StockNews.com debuted its coverage of CorVel for the very first time on October 12 with the publication of a research article. They recommended purchasing shares of the company as a whole.

CorVel Corporation offers solutions for workers’ compensation, auto, liability, and health insurance to assist employers, third-party administrators, insurance companies, and governmental organizations with managing medical expenses and monitoring the standard of care related to healthcare claims. These services are provided to assist with the management of healthcare claims. On their website, you can find the answers t

Tags: CRVL, Analyst Rating
Ronald Kaufman

Ronald Kaufman

Ronald Kaufman is a veteran analyst and researcher with an expertise in the fields of Pharma, Cyber, FoodTech and Blockchain. He has been published on entrepreneur.com, GuruFocus, Finextra Research and others. He is currently a researcher at the Future Markets Research Tank (FMRT), where he does deep-dive market analysis and research in a number of industries.

DISCLAIMER

Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.

The Best Stocks, its managers, its employees, affiliates and assigns (collectively “The Company”) do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above.

READ MORE

Categories

Best Stocks to buy now
Crypto
Dow Jones Today
Pre-IPO and Startups
Tech stocks
Utility Stocks

Data and Tools
Quote
Dow Jones Today

Follow us on Social Media
Facebook – YouTube – Twitter

Write for us
Finance – Business

Best Stocks to Buy Now

We are a financial media dedicated to providing stock recommendations, news, and real-time stock prices.

  • Disclaimer
  • Privacy Policy
  • Best stocks to buy now
  • Contact
  • Write for us – Finance, Crypto

© 2023 Best Stocks

No Result
View All Result
  • Home
  • News
  • Best stocks to buy now
  • Categories
    • Crypto
    • Dow Jones Today
    • Pre-IPO and Startups
    • Tech stocks
    • Utility Stocks
  • Best Stocks Tools
    • Stock News Sentiment
    • Stock Fundamentals Checker
    • Price Targets
    • Indices
  • About us
    • Contact

© 2023 Best Stocks